NCT05108025View on ClinicalTrials.gov

DMT310-005 Topical in the Treatment of Acne Rosacea

PHASE2UnknownINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Acne Rosacea
Interventions
DRUG

Topical Powder

Topical Powder mixed with diluent

DRUG

Placebo Topical Powder

Placebo Topical Powder mixed with diluent

Trial Locations (1)

78759

Dermata Investigational Site, Austin

Sponsors
All Listed Sponsors
lead

Dermata Therapeutics

INDUSTRY

NCT05108025 - DMT310-005 Topical in the Treatment of Acne Rosacea | Biotech Hunter | Biotech Hunter